Nasdaq:US$15.16 (+0.08) | HKEX:HK$23.20 (-0.30) | AIM:£2.24 (-0.01)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF